John Brancaccio
Chairman bei HEPION PHARMACEUTICALS, INC.
Vermögen: 24 579 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Gary Jacob | M | 77 |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 21 Jahre |
| Gabriele Cerrone | M | 52 |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY.
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 26 Jahre |
| Willy Simon | M | 72 | 9 Jahre | |
| Bernard Denoyer | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 17 Jahre |
| Keeren Shah | F | 47 | 8 Jahre | |
| Brigitte Lindsay | F | - | 12 Jahre | |
| Mark Erlander | M | 64 | 11 Jahre | |
| Vaseem Palejwala | M | - | 12 Jahre | |
| Vicki Kelemen | F | - | 9 Jahre | |
| Wendy Blosser | F | 57 | 2 Jahre | |
| Rodney Markin | M | 67 | 10 Jahre | |
| Renee Tannenbaum | M | 72 | 3 Jahre | |
| Kaouthar Lbiati | M | 45 | 2 Jahre | |
| Timothy Block | M | 69 | 11 Jahre | |
| John Cavan | M | 65 | 8 Jahre | |
| James Armitage | M | 77 | 4 Jahre | |
| William Clementi | M | - | 1 Jahre | |
| Sean McDonald | M | 63 | 2 Jahre | |
| Mani Mohindru | M | 52 | 3 Jahre | |
| Gary Pace | M | 76 | 4 Jahre | |
| Leslie M. Magnus | F | - | 9 Jahre | |
| Lâle White | F | 68 | 4 Jahre | |
| Matthew Davis | M | - | 2 Jahre | |
| James Levine | M | 53 | 3 Jahre | |
| Paul Spencer | M | - | 2 Jahre | |
| Paul Spencer | M | - | 2 Jahre | |
| Charles Monahan | M | - | 2 Jahre | |
| Tod Smeal | M | 59 | 2 Jahre | |
| Daren Ure | M | - | 5 Jahre | |
| Jules S. Jacob | M | - | 7 Jahre | |
| Daniel Trepanier | M | - | 5 Jahre | |
| Stephen Kilmer | M | - | - | |
| Raj Patil | M | 66 | 6 Jahre | |
| Erik de Clercq | M | - |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | 19 Jahre |
| Joe Flanagan | M | 49 | 2 Jahre | |
| Richard Whitley | M | 78 |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | 19 Jahre |
| Stephen Comiskey | M | - | 16 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kunwar Shailubhai | M | 67 | 20 Jahre | |
| Lawrence Kenyon | M | 58 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | 5 Jahre |
| Thomas H. Adams | M | 81 | 13 Jahre | |
| Christopher McGuigan | M | 65 |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | 6 Jahre |
| Charles Muniz | M | 69 |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | 2 Jahre |
| Bill Welch | M | 62 | 2 Jahre | |
| Craig C. Talluto | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 Jahre |
| Riccardo Dalla-Favera | M | 72 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 6 Jahre |
| Jim Tripp | M | 54 | - | |
| Robert Foster | M | 65 | 7 Jahre | |
| Alessandro Padova | M | 56 | 4 Jahre | |
| Troy Hamilton | M | 52 | 4 Jahre | |
| Melvin Spigelman | M | 75 | 11 Jahre | |
| Athena Countouriotis | M | 52 | 3 Jahre | |
| Peter Wijngaard | M | 61 | 3 Jahre | |
| Jeff Fensterer | M | 45 | 2 Jahre | |
| Laura Barrow | M | - | - | |
| Stanley Neal Tennant | M | 72 | 8 Jahre | |
| Joseph J. Farnan | M | 78 | - | |
| Bill Welch | M | - | 2 Jahre | |
| Theresa Matkovits | M | 56 | 3 Jahre | |
| Tiziano Lazzaretti | M | 65 | 4 Jahre | |
| Jamie Marie Sulley | M | - |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | - |
| Richard Daly | M | 62 | 3 Jahre | |
| Stephen K. Carter | M | 85 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | 13 Jahre |
| Timothy Sean Callahan | M | 53 | 4 Jahre | |
| James Sapirstein | M | 63 | 4 Jahre | |
| Anand Reddi | M | 42 | 2 Jahre | |
| Donald Picker | M | 78 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 5 Jahre |
| James Mervis | M | - | - | |
| Tamar Howson | F | 75 | 2 Jahre | |
| Andreas Braun | M | 67 | 1 Jahre | |
| Arnold Lippa | M | 77 | 8 Jahre | |
| Bruce A. Huebner | M | 73 | 1 Jahre | |
| Joseph M. Donabauer | M | 61 |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | 5 Jahre |
| Samuil Umansky | M | - | 7 Jahre | |
| Alan F. Joslyn | M | 65 | 10 Jahre | |
| Elizabeth Anderson | F | - | 2 Jahre | |
| Alex Martin Martin | M | 55 | 3 Jahre | |
| Randall K. Johnson | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 Jahre |
| Paul Billings | M | 71 | - | |
| Frederick Larcombe | M | 67 |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | 2 Jahre |
| Geoffrey W. Henson | M | 76 |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | 2 Jahre |
| David Sidransky | M | 64 |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | 13 Jahre |
| Antonius P. Schuh | M | 59 | 5 Jahre | |
| Chhaya Shah | F | 60 | 3 Jahre | |
| Gem Hopkins | M | - | - | |
| Brad Runge | M | - | 2 Jahre | |
| George Samuel | M | 43 | 3 Jahre | |
| Gregor MacRae | M | 61 | 1 Jahre | |
| Jason C. Poole | M | - | 2 Jahre | |
| Mark O'Hara | M | - | - | |
| Janel Dockter | F | - | - | |
| Gianluigi Longinotti-Buitoni | M | - | - | |
| Gail M. Comer | M | - | - | |
| Patrick Griffin | M | 68 | 5 Jahre | |
| Marino Garcia | M | 57 | 4 Jahre | |
| David Robbins | M | - | 6 Jahre | |
| Robert C. Shepard | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 7 Jahre |
| Abba David Poliakoff | M | 72 | - | |
| Gary Sender | M | 62 | 1 Jahre | |
| Gary Gemignani | M | 58 | 2 Jahre | |
| Oanh Dang | M | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 82 | 82,00% |
| Vereinigtes Königreich | 13 | 13,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- John Brancaccio
- Persönliches Netzwerk
